Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1Breast 1

Conditions

Breast Neoplasms 1931Neoplasms 1385Carcinoma, Non-Small-Cell Lung 1324Prostatic Neoplasms 1070Multiple Myeloma 855Leukemia, Myeloid, Acute 759Neoplasm Metastasis 691Colorectal Neoplasms 676Melanoma 666Lung Neoplasms 665Lymphoma 655Leukemia 591Lymphoma, Non-Hodgkin 587Leukemia, Lymphocytic, Chronic, B-Cell 529Ovarian Neoplasms 517Pancreatic Neoplasms 493Precursor Cell Lymphoblastic Leukemia-Lymphoma 471Recurrence 466Myelodysplastic Syndromes 421Lymphoma, Follicular 407Head and Neck Neoplasms 401Glioblastoma 376Carcinoma, Renal Cell 375Lymphoma, Large B-Cell, Diffuse 372Brain Neoplasms 370Hodgkin Disease 352Carcinoma, Hepatocellular 324Squamous Cell Carcinoma of Head and Neck 323Lymphoma, Mantle-Cell 302Sarcoma 281

Interventions

Temozolomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × Neoplasms, Second Primary × Clear all
NCT02530515 2019-10-29

Ex Vivo-activated Autologous Lymph Node Lymphocytes in Treating Patients With Chronic Lymphocytic Leukemia

M.D. Anderson Cancer Center

Phase 2 Completed
8 enrolled 6 charts
Classical hematologyLymphoidOther hematologic neoplasm

Lymphadenopathy, Anemia, Communicable Diseases, Fever, Lymphocytosis, Thrombocytopenia, Weight Loss, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Neoplasms, Second Primary

NCT00638963 2017-06-14

STOP

Merck Sharp & Dohme LLC

Phase 2 Terminated
6 enrolled 9 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡